STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 4] Movano Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Movano Inc. (MOVE) reported an insider equity change. On 11/03/2025, a director forfeited 12,442 previously awarded RSUs in lieu of directors’ fees and received a stock option for 55,250 shares at an exercise price of $1.25.

The option will become exercisable upon shareholder approval of an amendment increasing shares under the Omnibus Incentive Plan. Following the transactions, the director beneficially owned 2,690 common shares. The disclosed option lists an expiration date of 12/31/2025.

Positive
  • None.
Negative
  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
FAIRBAIRN EMILY

(Last) (First) (Middle)
C/O MOVANO, INC.
6800 KOLL CENTER PARKWAY

(Street)
PLEASANTON CA 94566

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Movano Inc. [ MOVE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
11/03/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/03/2025 D 12,442(1) D $0 2,690 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock option (right to buy) $1.25 11/03/2025 A 55,250 (2) 12/31/2025 Common Stock 55,250 $0 55,250 D
Explanation of Responses:
1. The reported transaction involved the reporting person's forfeiture of previously awarded restricted stock units ("RSUs") under the Company's Omnibus Inctive Plan (the "Omnibus Incentive Plan") in lieu of directors' fees in exchange for the grant of stock options.
2. This option award was granted contingent upon shareholder approval of an amendment to the Omnibus Incentive Plan that increases the number of shares of Common Stock authorized for issuance under the Plan (the "Plan Amendment"). The option will become exerciseable upon shareholder approval of the Plan Amendment.
/s/ Emily Fairbairn by Mark R. Busch, attorney-in-fact 11/10/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Movano (MOVE) disclose in this Form 4?

A director forfeited 12,442 RSUs and received a stock option for 55,250 shares at $1.25 per share on 11/03/2025.

Is the new stock option immediately exercisable for MOVE?

No. It becomes exercisable upon shareholder approval of an amendment to the Omnibus Incentive Plan.

What is the exercise price and size of the option granted at Movano?

The option covers 55,250 shares at an exercise price of $1.25 per share.

How many MOVE shares does the director own after the transactions?

Beneficial ownership after the reported transactions is 2,690 common shares.

Why were the RSUs forfeited by the Movano director?

Per the filing, RSUs were forfeited in lieu of directors’ fees in exchange for the grant of stock options.

What is the disclosed expiration date of the new option?

The option lists an expiration date of 12/31/2025 as disclosed.
Movano Inc

NASDAQ:MOVE

MOVE Rankings

MOVE Latest News

MOVE Latest SEC Filings

MOVE Stock Data

3.98M
587.34k
24.94%
15.13%
13.54%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
PLEASANTON